thiophenes has been researched along with Fracture, Pathologic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hijikata, Y; Matsubara, Y; Watanabe, N | 1 |
| Novak, S | 1 |
| Chappard, D; de Vernejoul, MC; Geoffroy, V; Lalande, A; Libouban, H; Marty, C; Ostertag, A | 1 |
| Biskobing, DM; Downs, R; Novy, AM | 1 |
| Badurski, JE; Balogh, A; Cannata, J; Genant, HK; Lemmel, EM; Meunier, PJ; Ortolani, S; Pors-Nielsen, S; Reginster, JY; Rizzoli, R; Roux, C; Seeman, E; Spector, TD | 1 |
| Dimai, HP | 1 |
| Fassbender, WJ; Stumpf, UC | 1 |
| Briot, K; Roux, C; Thomas, T; Trémollières, F | 1 |
| Rafeiner, P | 1 |
| Díez Pérez, A | 1 |
| Meunier, PJ | 1 |
7 review(s) available for thiophenes and Fracture, Pathologic
| Article | Year |
|---|---|
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Topics: Antibodies, Monoclonal; Bias; Bone Density; Bone Density Conservation Agents; Denosumab; Female; Femur Neck; Fractures, Spontaneous; Hip; Humans; Indoles; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Parathyroid Hormone-Related Protein; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Spinal Fractures; Teriparatide; Thiophenes; Watchful Waiting | 2021 |
[The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
Topics: Bone Density Conservation Agents; Fractures, Spontaneous; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes | 2008 |
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
[Strontium ranelate: a novel concept for the treatment of osteoporosis].
Topics: Animals; Bone Density; Bone Development; Bone Resorption; Clinical Trials as Topic; Fractures, Spontaneous; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2005 |
How long should patients take medications for postmenopausal osteoporosis?
Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Drug Administration Schedule; Drug Monitoring; Etidronic Acid; Female; Fractures, Spontaneous; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Risk Assessment; Teriparatide; Thiophenes; Time Factors; Treatment Outcome | 2007 |
[Osteoporosis: basics and pitfalls].
Topics: Absorptiometry, Photon; Aged; Diphosphonates; Estrogen Receptor Modulators; Female; Fractures, Spontaneous; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Practice Guidelines as Topic; Primary Health Care; Risk Factors; Thiophenes | 2007 |
Anabolic agents for treating postmenopausal osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Female; Fluorides; Fractures, Spontaneous; Growth Hormone; Humans; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Simvastatin; Thiophenes | 2001 |
1 trial(s) available for thiophenes and Fracture, Pathologic
| Article | Year |
|---|---|
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Biomarkers; Biopsy; Bone and Bones; Bone Density; Calcium; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Femur Neck; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Prospective Studies; Radiography; Risk; Secondary Prevention; Spinal Fractures; Strontium; Thiophenes; Thoracic Vertebrae; Treatment Outcome | 2004 |
3 other study(ies) available for thiophenes and Fracture, Pathologic
| Article | Year |
|---|---|
Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
Topics: Animals; Bone Density Conservation Agents; Calcium; Cauda Equina; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fractures, Spontaneous; Lumbar Vertebrae; Mice; Mice, Transgenic; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Spinal Fractures; Stress, Mechanical; Strontium; Thiophenes; Tibia | 2011 |
[DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Spontaneous; Humans; Ibandronic Acid; Male; Middle Aged; Minimally Invasive Surgical Procedures; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Peptide Fragments; Recombinant Proteins; Spinal Fractures; Teriparatide; Thiophenes | 2006 |
[Therapeutics issues in osteoporosis].
Topics: Aged; Bone Remodeling; Bone Resorption; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Spontaneous; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes | 2007 |